- Home
- M vs SLNO Comparison
M vs SLNO Comparison
Compare M & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- M
- SLNO
- Stock Information
- Founded
- M 1830
- SLNO 1999
- Country
- M United States
- SLNO United States
- Employees
- M N/A
- SLNO N/A
- Industry
- M Department/Specialty Retail Stores
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- M Consumer Discretionary
- SLNO Health Care
- Exchange
- M Nasdaq
- SLNO Nasdaq
- Market Cap
- M 3.5B
- SLNO 3.8B
- IPO Year
- M N/A
- SLNO 2014
- Fundamental
- Price
- M $16.95
- SLNO $53.62
- Analyst Decision
- M Hold
- SLNO Strong Buy
- Analyst Count
- M 10
- SLNO 10
- Target Price
- M $15.06
- SLNO $112.50
- AVG Volume (30 Days)
- M 11.3M
- SLNO 1.9M
- Earning Date
- M 09-03-2025
- SLNO 11-05-2025
- Dividend Yield
- M 4.30%
- SLNO N/A
- EPS Growth
- M 304.55
- SLNO N/A
- EPS
- M 1.77
- SLNO N/A
- Revenue
- M $22,701,000,000.00
- SLNO $32,656,999.00
- Revenue This Year
- M N/A
- SLNO N/A
- Revenue Next Year
- M N/A
- SLNO $175.39
- P/E Ratio
- M $9.61
- SLNO N/A
- Revenue Growth
- M N/A
- SLNO N/A
- 52 Week Low
- M $9.76
- SLNO $41.50
- 52 Week High
- M $18.13
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- M 70.68
- SLNO 25.04
- Support Level
- M $13.09
- SLNO $50.63
- Resistance Level
- M $17.62
- SLNO $72.99
- Average True Range (ATR)
- M 0.58
- SLNO 4.32
- MACD
- M 0.27
- SLNO -1.00
- Stochastic Oscillator
- M 84.46
- SLNO 13.37
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.